HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wollowski, I. Articles by Pool-Zobel, B. L Search for Related Content PubMed PubMed Citation Articles by Wollowski, I. Articles by Pool-Zobel, B. L Agricola Articles by Wollowski, I. Articles by Pool-Zobel, B. L

Protective role of probiotics and prebiotics in colon cancer^1,2,3

¹ From the Institute for Nutritional Physiology, Federal Research Centre for Nutrition, Karlsruhe, Germany, and the Department of Molecular Toxicology and Pharmacogenetics, Institute for Nutrition and Environment, Friedrich-Schiller-University Jena, Germany.

Ingestion of viable probiotics or prebiotics is associated with anticarcinogenic effects, one mechanism of which is the detoxification of genotoxins in the gut. This mechanism was shown experimentally in animals with use of the rat colon carcinogen 1,2-dimethylhydrazine and by determining endpoints that range from tumorigenesis to induction of DNA damage. Because of the complexity of cancer initiation, cancer progression, and the exposure of cancer in the gut, many types of interactions may be envisaged. Notably, some of our newer studies showed that short-lived metabolite mixtures isolated from milk that was fermented with strains of Lactobacillus bulgaricus and Streptococcus thermophilus are more effective in deactivating etiologic risk factors of colon carcinogenesis than are cellular components of microorganisms. Ingestion of prebiotics results in a different spectrum of fermentation products, including the production of high concentrations of short-chain fatty acids. Gut flora, especially after the ingestion of resistant starch, induces the chemopreventive enzyme glutathione transferase in the colon of the rat. Together, these factors lead to a reduced load of genotoxic agents in the gut and to an increased production of agents that deactivate toxic components. Butyrate is one such protective agent and is associated with lowering cancer risk. It was recently shown that buytrate may inhibit the genotoxic activity of nitrosamides and hydrogen peroxide in human colon cells. In humans, the ingestion of probiotics leads to the excretion of urine with low concentrations of components that are genotoxic in human colon cells and high concentrations of components that induce oxidized DNA bases.

Key Words: Probiotics • prebiotics • lactic acid bacteria • microflora • colon cancer • protective mechanisms • antigenotoxicity • fermentation • short-chain fatty acids • butyrate

This article has been cited by other articles:

				V. Van Craeyveld, K. Swennen, E. Dornez, T. Van de Wiele, M. Marzorati, W. Verstraete, Y. Delaedt, O. Onagbesan, E. Decuypere, J. Buyse, et al. Structurally Different Wheat-Derived Arabinoxylooligosaccharides Have Different Prebiotic and Fermentation Properties in Rats J. Nutr., December 1, 2008; 138(12): 2348 - 2355. [Abstract] [Full Text] [PDF]

				M. Blaut and T. Clavel Metabolic Diversity of the Intestinal Microbiota: Implications for Health and Disease J. Nutr., March 1, 2007; 137(3): 751S - 755S. [Abstract] [Full Text] [PDF]

				C. M. Galdeano and G. Perdigon The Probiotic Bacterium Lactobacillus casei Induces Activation of the Gut Mucosal Immune System through Innate Immunity Clin. Vaccine Immunol., February 1, 2006; 13(2): 219 - 226. [Abstract] [Full Text] [PDF]

				R. K. Le Leu, I. L. Brown, Y. Hu, A. R. Bird, M. Jackson, A. Esterman, and G. P. Young A Synbiotic Combination of Resistant Starch and Bifidobacterium lactis Facilitates Apoptotic Deletion of Carcinogen-Damaged Cells in Rat Colon J. Nutr., May 1, 2005; 135(5): 996 - 1001. [Abstract] [Full Text] [PDF]

				M. Zsivkovits, K. Fekadu, G. Sontag, U. Nabinger, W. W. Huber, M. Kundi, A. Chakraborty, H. Foissy, and S. Knasmuller Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains Carcinogenesis, December 1, 2003; 24(12): 1913 - 1918. [Abstract] [Full Text] [PDF]

				A. P. Femia, C. Luceri, P. Dolara, A. Giannini, A. Biggeri, M. Salvadori, Y. Clune, K. J. Collins, M. Paglierani, and G. Caderni Antitumorigenic activity of the prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis on azoxymethane-induced colon carcinogenesis in rats Carcinogenesis, November 1, 2002; 23(11): 1953 - 1960. [Abstract] [Full Text] [PDF]

				M. B Roberfroid Prebiotics: preferential substrates for specific germs? Am. J. Clinical Nutrition, February 1, 2001; 73(2): 406S - 409. [Abstract] [Full Text] [PDF]

				P. R Marteau, M. d. Vrese, C. J Cellier, and J. Schrezenmeir Protection from gastrointestinal diseases with the use of probiotics Am. J. Clinical Nutrition, February 1, 2001; 73(2): 430S - 436. [Abstract] [Full Text] [PDF]